BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12208252)

  • 1. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
    Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
    Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.
    Wilson MR
    Trans Am Ophthalmol Soc; 2002; 100():365-410. PubMed ID: 12545702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma.
    Chen PP; Park RJ
    Ophthalmology; 2000 Sep; 107(9):1688-92. PubMed ID: 10964831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of visual field progression between eyes in patients with open-angle glaucoma.
    Chen PP
    Ophthalmology; 2002 Nov; 109(11):2093-9. PubMed ID: 12414421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deterioration of visual fields in patients with glaucoma with and without optic disc hemorrhages.
    Rasker MT; van den Enden A; Bakker D; Hoyng PF
    Arch Ophthalmol; 1997 Oct; 115(10):1257-62. PubMed ID: 9338670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.
    Am J Ophthalmol; 2000 Oct; 130(4):429-40. PubMed ID: 11024415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fellow eye prognosis in patients with severe visual field loss in 1 eye from chronic open-angle glaucoma.
    Chen PP; Bhandari A
    Arch Ophthalmol; 2000 Apr; 118(4):473-8. PubMed ID: 10766132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
    Tanito M; Itai N; Dong J; Ohira A; Chihara E
    Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
    Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK;
    Ophthalmology; 2009 Feb; 116(2):200-7. PubMed ID: 19019444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields.
    Sample PA; Boden C; Zhang Z; Pascual J; Lee TW; Zangwill LM; Weinreb RN; Crowston JG; Hoffmann EM; Medeiros FA; Sejnowski T; Goldbaum M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3684-92. PubMed ID: 16186350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline prognostic factors predict rapid visual field deterioration in glaucoma.
    Lee JM; Caprioli J; Nouri-Mahdavi K; Afifi AA; Morales E; Ramanathan M; Yu F; Coleman AL
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2228-36. PubMed ID: 24458154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.